Biocon's Mazumdar Shaw Says Firm On Track To Be Top Insulin Maker
Source:
bloombergMarkets
June 15, 2026 · 18:40
Biocon founder Kiran Mazumdar Shaw says she is confident that the company's investment and capacity expansion in Insulin will make the company the top hub for the drug in the next five years. She speaks in an exclusive conversation with Bloomberg's Haslinda Amin. (Source: Bloomberg)
The original article opens on the publisher's website.
More from General
View topic →Incumbent Sen. Ed Markey wins Massachusetts' Democratic primary for US Senate
nprNews
Sep 1, 2026 · 17:38
Apple Maps changes Lake Ontario to Lake America after Trump order
bbcTechnology
Sep 1, 2026 · 17:36
Bill Simmons’s Co-Hosts Are Tired of His A.I. Antics
nytimes
Sep 1, 2026 · 16:57
Tim Cook to be paid $47mn as Apple’s executive chair
financialTimes
Sep 1, 2026 · 16:38
Are all TVs at risk from burn-in? Here's how to avoid the problem altogether
engadget
Sep 1, 2026 · 16:30